PNC Financial Services Group’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
RI
DC
TCM
PNC Financial Services Group's CGON Position: Q2 2026 in Review
PNC Financial Services Group increased its CG Oncology (CGON) stake by 20% in Q2 2026, buying an estimated $34.9K and bringing the position to 3,262 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #2360.
PNC Financial Services Group first reported a position in CGON in Q2 2024 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.
- PNC Financial Services Group held 3,262 shares of CG Oncology worth $232K as of Q2 2026.
- PNC Financial Services Group bought 534 CG Oncology shares in Q2 2026, an estimated $34.9K.
- CG Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2360 holding.
- PNC Financial Services Group first reported a position in CG Oncology in Q2 2024 and has held it in 9 quarters since.
- 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.